Wacker Chemie AG (WCH)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 82.35 |
|---|---|
| 52-week range | 62.25 – 105.60 |
| Return, 1 month / 3 months | −5.8% / −4.0% |
| Return, 1 year / 3 years | +21.5% / −20.7% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 43.7% |
| Worst drawdown (1 year) | -25.4% |
| Average daily value traded | 4.80M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wacker Chemie AG is a German chemical company based in Munich. It produces polysilicon for the solar and semiconductor industries, along with silicones, polymer binders and other specialty chemicals. Its customers include manufacturers of solar modules and electronic components, construction and coatings companies, and industrial processors who use its chemical products. The company also supplies silicon wafers and operates in biotechnology through its chemical and life-science divisions, serving industrial and consumer markets across Europe and beyond.
On this site Wacker Chemie AG appears as a stock on the Deutsche Börse Xetra (Germany), code WCH, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wacker Chemie AG (WCH) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 82.35 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 349 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.5% and over the last three months it fell 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.7% | ||
| From 52-week high | -22.0% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.0% | ||
| 6-month return | -13.6% | ||
| 12-month return, skipping the last month | 29.0% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.4% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 4.80M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.6% |
|---|---|
| 1 month | −5.8% |
| 3 months | −4.0% |
| 6 months | −13.6% |
| 1 year | +21.5% |
| 3 years | −20.7% |
| 5 years | −34.0% |
Signals
| 50-day / 200-day average | 88.65 / 87.35 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | EUR 1.0000 |
| 8 May 2025 | EUR 2.5000 |
| 9 May 2024 | EUR 3.0000 |
| 18 May 2023 | EUR 12.0000 |
| 23 May 2022 | EUR 8.0000 |
| 13 May 2021 | EUR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.